2Firsts Exclusive PMTA Product: PMTA SUPER MODULE PLAN

May.22.2025
2Firsts Exclusive PMTA Product: PMTA SUPER MODULE PLAN
2Firsts launches an exclusive PMTA Super Service Plan featuring the Acceptance Pro Solution and SciAsset Filing Plans.

2Firsts exclusive PMTA product

 

PMTA SUPER SERVICE PLAN

 

 

Acceptance Pro Solution -- 20k $(10 sku)

SciAsset Filing Plans -- 50K $ (10 sku)

 

Current US Market

 

· Disposable devices were mostly illicit products that have not been Pre-market authorized by FDA .

· Nicotine pouch related products are booming and growing fast.

· Other type of product such as IOQS Heated Tobacco products are also increasing in the market share.

· Multiple States are requiring products to get PMTA registry in directory before entering each state market.

 

Acceptance Pro Solution

 

·The minimum compliance threshold for NPG products entering the US market

· Exclusive Scientific PMTA Acceptance Solution developed by 2Firsts

 

About 2Firsts Acceptance Pro Solution

2Firsts Acceptance Pro Solutions is a science based enhanced PMTA submission service exclusively launched by 2Firsts. Intended to help new NGP products smoothly to obtain FDA Acceptance Letters - to pass the first compliance threshold for entering the US market.

 

Intended Client for 2First Acceptance Pro Solution

· Help client to export electronic cigarettes, heated tobacco product and nicotine pouch to the United States in a legal manner

· Brands intending to expand their legal market share in the United States in the next year

· Brand clients intend to register the products in the PMTA directory list of different states

 

2FIRST Acceptance Pro Service Advantage

2Firsts Exclusive PMTA Product: PMTA SUPER MODULE PLAN

 

·Cost for Acceptance Pro Solution is 20,000$ for 10SKU

·Cost explanation: The PMTA submission service at least 10 sku for each product and costs do not contain testing fee

 

SciAsset Filing Plans

 

·Develop products with long-term compliance value and potential for capital premium.

·The scientific pathway exclusively developed by 2Firsts to make new NGP products a "regulatory asset" in the US market.

 

About SciAsset Filing Plan by 2Firsts

SciAsset Filing is a high-level PMTA robust submission service developed by 2Firsts specifically for new tobacco products (NGPs). Only costs effective PMTA filing plan service provided globally.

 

SciAsset Filing service will make your product to become an in-depth scientific and compliance value asset in US market, it will also help your product PMTA enter into substantive review phase.

 

Value of SciAsset Filing Service

Have capability to bring product PMTA application into scientific review phase.

Becoming the positioning foundation of "regulatory assets", it can support financing, brand mergers and acquisitions, and capital valuation, with longer sales periods and lower risk of credit default.

Can expand to FULL PMTA plan, formulate top compliance potential in US market.

 

Intended company for SciAsset Filing Plan

· Enterprises with long-term strategic layout for the US market

· Let the US compliance product to become the “ top priority “ for the investor and big tobacco hunter in the US market.

·Company that already received PMTA Acceptance letter, hope to get higher level successful achievement in PMTA application.

 

2FIRSTS PMTA SciAsset Filing Plan Advantage

2Firsts Exclusive PMTA Product: PMTA SUPER MODULE PLAN

 

·Cost for SciAsset Filing Plan is 50,000 $ USD for 10 sku

·Cost explanation: The PMTA submission service at least 10 sku for each product and costs do not contain testing fee

 

Contact Us

 

Michelle Zhang

Email:zhangmixuan@2firsts.com

WhatsApp:+79099950122 

 

Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
mperial Brands has launched blu MAX 6000 in the UK, positioning the product as a higher-puff vape kit with longer-lasting use and replaceable pod+refill options. The device uses a 2ml+10ml click-on box format, with starter kits priced at £10.99 (approximately $14) and replacement pod+refill packs priced at £7.99 (approximately $10).
Market
May.19
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
One Year After UK Disposable Vape Ban: Youth Use Falls to 13%, Adult Use to 8%
One Year After UK Disposable Vape Ban: Youth Use Falls to 13%, Adult Use to 8%
among both youth and adults. However, industry groups and regulators warn that the illicit vape market remains a growing concern.
Jun.09
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India’s Directorate of Revenue Intelligence (DRI) seized approximately 300,000 illegal e-cigarettes and vaping devices worth more than ₹120 crore (approximately $14 million) during coordinated multi-state enforcement operations.
Regulations
May.22
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
China’s e-cigarette export value declined to $694 million in April 2026, marking the lowest April level in the past three years. The data is notable because April was the first full month after China removed export VAT rebates for certain e-cigarette products. Compared with April 2025, export value fell 20.9%; compared with April 2024, it was down 22.3%. Month-on-month, exports dropped 23.2% from March 2026.
Special Report
May.23
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13